Invention Grant
US09109032B2 Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
有权
通过靶向在骨髓异常脉管系统中表达的EphA3来治疗血液增殖性疾病的方法
- Patent Title: Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
- Patent Title (中): 通过靶向在骨髓异常脉管系统中表达的EphA3来治疗血液增殖性疾病的方法
-
Application No.: US13571827Application Date: 2012-08-10
-
Publication No.: US09109032B2Publication Date: 2015-08-18
- Inventor: Geoffrey T. Yarranton , Varghese Palath , Christopher R. Bebbington , Mark Baer
- Applicant: Geoffrey T. Yarranton , Varghese Palath , Christopher R. Bebbington , Mark Baer
- Applicant Address: US CA South San Francisco
- Assignee: KaloBios Pharmaceuticals, Inc.
- Current Assignee: KaloBios Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; G01N33/68
Abstract:
The invention provides diagnostic and therapeutic methods for the treatment of hematological proliferative disorders.
Public/Granted literature
Information query
